133 related articles for article (PubMed ID: 17695450)
1. Evaluation of prognostic value of VEGF-C and VEGF-D in breast cancer--10 years follow-up analysis.
Gisterek I; Matkowski R; Koźlak J; Duś D; Lacko A; Szelachowska J; Kornafel J
Anticancer Res; 2007; 27(4C):2797-802. PubMed ID: 17695450
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of vascular endothelial growth factor D in breast carcinoma with long-term follow-up.
Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
Clin Cancer Res; 2003 Feb; 9(2):716-21. PubMed ID: 12576440
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast carcinoma.
Mylona E; Alexandrou P; Mpakali A; Giannopoulou I; Liapis G; Markaki S; Keramopoulos A; Nakopoulou L
Eur J Surg Oncol; 2007 Apr; 33(3):294-300. PubMed ID: 17129704
[TBL] [Abstract][Full Text] [Related]
5. Expression of hypoxia-inducible factor (HIF-1alpha), VEGF-C and VEGF-D in non-invasive and invasive breast ductal carcinomas.
Okada K; Osaki M; Araki K; Ishiguro K; Ito H; Ohgi S
Anticancer Res; 2005; 25(4):3003-9. PubMed ID: 16080559
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological significance of vascular endothelial growth factor-C in breast carcinoma with long-term follow-up.
Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Tsukiyama A; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
Mod Pathol; 2003 Apr; 16(4):309-14. PubMed ID: 12692195
[TBL] [Abstract][Full Text] [Related]
7. ErbB2 overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human breast carcinoma.
Yang W; Klos K; Yang Y; Smith TL; Shi D; Yu D
Cancer; 2002 Jun; 94(11):2855-61. PubMed ID: 12115372
[TBL] [Abstract][Full Text] [Related]
8. VEGF-C, VEGF-D and Flt-4 in transitional bladder cancer: relationships to clinicopathological parameters and long-term survival.
Herrmann E; Eltze E; Bierer S; Köpke T; Görge T; Neumann J; Hertle L; Wülfing C
Anticancer Res; 2007; 27(5A):3127-33. PubMed ID: 17970053
[TBL] [Abstract][Full Text] [Related]
9. Role of vascular endothelial growth factor-C and -D mRNA in breast cancer.
Teramoto S; Arihiro K; Koseki M; Kataoka T; Asahara T; Ohdan H
Hiroshima J Med Sci; 2008 Jun; 57(2):73-8. PubMed ID: 18717190
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer.
Carrillo de Santa Pau E; Arias FC; Caso Peláez E; Muñoz Molina GM; Sánchez Hernández I; Muguruza Trueba I; Moreno Balsalobre R; Sacristán López S; Gómez Pinillos A; del Val Toledo Lobo M
Cancer; 2009 Apr; 115(8):1701-12. PubMed ID: 19197998
[TBL] [Abstract][Full Text] [Related]
11. [Clinical characteristics and prognosis of breast cancer patients with vascular invasion].
Zhao WH; Xu BH; Zhang P; Li Q; Zhao LM; Sun Y
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):137-40. PubMed ID: 17645853
[TBL] [Abstract][Full Text] [Related]
12. Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer.
Zhang XH; Huang DP; Guo GL; Chen GR; Zhang HX; Wan L; Chen SY
BMC Cancer; 2008 Jan; 8():4. PubMed ID: 18190720
[TBL] [Abstract][Full Text] [Related]
13. The expression of ER beta protein correlates with vascular endothelial growth factor and its prognostic significance in human breast cancer.
Wen XF; Shen Z; Shen ZZ; Nguyen M; Shao ZM
Oncol Rep; 2002; 9(5):937-44. PubMed ID: 12168051
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of the prognostic significance of vascular endothelial growth factor in node positive primary breast carcinoma.
MacConmara M; O'Hanlon DM; Kiely MJ; Connolly Y; Jeffers M; Keane FB
Int J Oncol; 2002 Apr; 20(4):717-21. PubMed ID: 11894115
[TBL] [Abstract][Full Text] [Related]
15. Absence of lymphangiogenesis in ductal breast cancer at the primary tumor site.
van der Schaft DW; Pauwels P; Hulsmans S; Zimmermann M; van de Poll-Franse LV; Griffioen AW
Cancer Lett; 2007 Aug; 254(1):128-36. PubMed ID: 17442484
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide in breast cancer: induction of vascular endothelial growth factor-C and correlation with metastasis and poor prognosis.
Nakamura Y; Yasuoka H; Tsujimoto M; Yoshidome K; Nakahara M; Nakao K; Nakamura M; Kakudo K
Clin Cancer Res; 2006 Feb; 12(4):1201-7. PubMed ID: 16489074
[TBL] [Abstract][Full Text] [Related]
17. The association between vascular endothelial growth factor-C, its corresponding receptor, VEGFR-3, and prognosis in primary breast cancer: a study with 193 cases.
Bando H; Weich HA; Horiguchi S; Funata N; Ogawa T; Toi M
Oncol Rep; 2006 Mar; 15(3):653-9. PubMed ID: 16465426
[TBL] [Abstract][Full Text] [Related]
18. [Significance of microvascular density and vascular endothelial growth factor in breast cancer].
Li J; Song ST; Jiang ZF; Liu XQ; Yan LD
Zhonghua Zhong Liu Za Zhi; 2003 Mar; 25(2):145-8. PubMed ID: 12795840
[TBL] [Abstract][Full Text] [Related]
19. Angiopoietin 2 expression in invasive ductal carcinoma of the breast: its relationship to the VEGF expression and microvessel density.
Tsutsui S; Inoue H; Yasuda K; Suzuki K; Takeuchi H; Nishizaki T; Higashi H; Era S; Mori M
Breast Cancer Res Treat; 2006 Aug; 98(3):261-6. PubMed ID: 16538528
[TBL] [Abstract][Full Text] [Related]
20. [Expression correlation of Ki67 to P53,VEGF,and C-erbB-2 genes in breast cancer and their clinical significances].
Li BJ; Zhu ZH; Wang JY; Hou JH; Zhao JM; Zhang PY; Yao GY; Wang X; Long H; Yang MT; Rong TH
Ai Zheng; 2004 Oct; 23(10):1176-9. PubMed ID: 15473930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
